Biodyne Statistics

Total Valuation

Biodyne has a market cap or net worth of KRW 437.53 billion. The enterprise value is 416.83 billion.

Market Cap	437.53B
Enterprise Value	416.83B

Important Dates

The next estimated earnings date is Wednesday, May 14, 2025.

Earnings Date	May 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Biodyne has 29.76 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	29.76M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	46.56%
Owned by Institutions (%)	1.11%
Float	15.91M

Valuation Ratios

The trailing PE ratio is 40,624.83 and the forward PE ratio is 107.30.

PE Ratio	40,624.83
Forward PE	107.30
PS Ratio	83.00
PB Ratio	10.13
P/TBV Ratio	10.98
P/FCF Ratio	1,293.47
P/OCF Ratio	498.66
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	38,702.71
EV / Sales	79.07
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	1,232.27

Financial Position

The company has a current ratio of 19.48, with a Debt / Equity ratio of 0.00.

Current Ratio	19.48
Quick Ratio	18.96
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	0.04
Interest Coverage	-9,941.41

Financial Efficiency

Return on equity (ROE) is 0.02% and return on invested capital (ROIC) is -2.50%.

Return on Equity (ROE)	0.02%
Return on Assets (ROA)	-2.45%
Return on Invested Capital (ROIC)	-2.50%
Return on Capital Employed (ROCE)	-4.00%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.12
Inventory Turnover	6.51

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +70.77% in the last 52 weeks. The beta is 1.81, so Biodyne's price volatility has been higher than the market average.

Beta (5Y)	1.81
52-Week Price Change	+70.77%
50-Day Moving Average	13,328.00
200-Day Moving Average	15,759.80
Relative Strength Index (RSI)	61.27
Average Volume (20 Days)	103,846

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Biodyne had revenue of KRW 5.27 billion and earned 10.77 million in profits.

Revenue	5.27B
Gross Profit	2.44B
Operating Income	-1.73B
Pretax Income	-141.10M
Net Income	10.77M
EBITDA	-107.90M
EBIT	-1.73B
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has 20.71 billion in cash and 12.07 million in debt, giving a net cash position of 20.70 billion or 695.52 per share.

Cash & Cash Equivalents	20.71B
Total Debt	12.07M
Net Cash	20.70B
Net Cash Per Share	695.52
Equity (Book Value)	43.20B
Book Value Per Share	n/a
Working Capital	21.21B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 877.41 million and capital expenditures -539.15 million, giving a free cash flow of 338.26 million.

Operating Cash Flow	877.41M
Capital Expenditures	-539.15M
Free Cash Flow	338.26M
FCF Per Share	11.36

Full Cash Flow Statement

Margins

Gross margin is 46.25%, with operating and profit margins of -32.82% and 0.20%.

Gross Margin	46.25%
Operating Margin	-32.82%
Pretax Margin	-2.68%
Profit Margin	0.20%
EBITDA Margin	-2.05%
EBIT Margin	-32.82%
FCF Margin	6.42%

Dividends & Yields

Biodyne does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	0.00%
FCF Yield	0.08%

Stock Splits

The last stock split was on February 28, 2024. It was a forward split with a ratio of 5.

Last Split Date	Feb 28, 2024
Split Type	Forward
Split Ratio	5

Scores

Biodyne has an Altman Z-Score of 217.67.

Altman Z-Score	217.67
Piotroski F-Score	n/a